Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Cationic Amphipathic Drugs

Figure 5.1 The structures of chloroquine and chlorphen-termine, two CADs showing the hydrophilic and hydrophobic regions. Abbreviation CAD, cationic amphipathic drug. Figure 5.1 The structures of chloroquine and chlorphen-termine, two CADs showing the hydrophilic and hydrophobic regions. Abbreviation CAD, cationic amphipathic drug.
It seems that for drugs to cause accumulation of phospholipids, the necessary physicochemical characteristic is the presence of both hydrophilic and lipophilic parts to the molecule, as exemplified by chlorphentermine (see chap. 3) (chap. 5, Fig. 1). They contain a hydrophobic ring structure and a hydrophilic side chain with a positively charged (cationic) amine group. Such molecules are known as cationic amphipathic drugs or CADs. Other drugs, all in use, known to cause phospholipidosis are amiodarone, chloroquine (chap. 5, Fig. 1), tafenoquine, and gentamycin. [Pg.225]


See other pages where Cationic Amphipathic Drugs is mentioned: [Pg.153]    [Pg.129]    [Pg.429]    [Pg.35]    [Pg.163]    [Pg.172]    [Pg.173]    [Pg.62]    [Pg.214]    [Pg.314]    [Pg.324]    [Pg.122]    [Pg.793]    [Pg.257]    [Pg.59]    [Pg.281]    [Pg.793]    [Pg.16]    [Pg.140]    [Pg.399]    [Pg.100]    [Pg.328]   
See also in sourсe #XX -- [ Pg.129 ]




SEARCH



Amphipathic

Amphipathicity

Amphipaths

Cationic drug

© 2024 chempedia.info